BTIG Reiterates Buy Rating on MiniMed Group (MMED)
BTIG analyst Marie Thibault reiterated a Buy rating and $25.00 price target on MiniMed Group (NASDAQ: MMED).The analyst comments "MiniMed ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
